AIMS testing in outpatients on SGA's

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
I have a hunch that if you studied this, you'd find that it's like most operational recommendations: the bigger the operation or system, the most likely that this gets done. The further out and more independent, the less likely.

VAs, prisons, and academic centers tend to document AIMS testing (and often have triggered reminders from their EMRs).
 
how often do you all do AIMS testing?

to what degree do you think this is still standard of care in modern psychiatry?

3-6 months is textbook recommendation for persons on antipsychotics.

Any thoughts would be greatly appreciated.

3-6 months when starting or if there is hx of EPS, 6 months indefinitely for 1st gens. For 2nd gens, yearly once on the medication for a year if there is no EPS. We document ours in the EMR with a tool just like Height/wt/BP would be, it's remarkably efficient/easy
 
Any reason to care if it's a SGA or FGA? Given the mechanism of EPS, wouldn't splitting them apart by potency make more sense, if you had to split them at all?
 
Any reason to care if it's a SGA or FGA? Given the mechanism of EPS, wouldn't splitting them apart by potency make more sense, if you had to split them at all?

I was just reporting what the protocol was at the psychosis clinic I worked at in residency for discussion. You bring up a very good point that checking a thorazine patient q6 months but a risperidone q 12 months does not make much sense!
 
Top